CD86 and liver dysplastic nodule: In this study, senescence markers (such as P16INK4a), inflammatory macrophage phenotypes (CD86, CD163, MCP-1), and immunometabolic enzymes (SDH, ACLY) were evaluated as downstream mechanistic responses to DN rather than as diagnostic criteria for diabetes or DN themselves.